{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:25:14Z","timestamp":1772249114363,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.urolonc.2013.08.029","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T14:15:30Z","timestamp":1388844930000},"page":"309-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Highlights from the first symposium on upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"32","author":[{"given":"Surena F.","family":"Matin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew I.","family":"Milowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna E.","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Koppie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Bajorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur P.","family":"Grollman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.08.029_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.ju.0000086551.22844.cd","article-title":"Microsatellite instability in urothelial carcinoma of the upper urinary tract","volume":"170","author":"Amira","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib3","first-page":"6796","article-title":"Frequent microsatellite instability in sporadic tumors of the upper urinary tract","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.08.029_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum","volume":"54","author":"Roupret","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib6","series-title":"Clinical Nephrotoxins","first-page":"588","article-title":"Balkan endemic nephropathy","author":"Djukanovi\u0107","year":"2003"},{"key":"10.1016\/j.urolonc.2013.08.029_bib7","series-title":"Clinical Nephrotoxins","first-page":"579","article-title":"Aristolochic acid nephropathy after Chinese herb remedies","author":"Vanherweghem","year":"2003"},{"key":"10.1016\/j.urolonc.2013.08.029_bib8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2013.08.029_bib9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/ki.1994.220","article-title":"Chinese herbs nephropathy: a clue to Balkan endemic nephropathy?","volume":"45","author":"Cosyns","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib10","first-page":"116","article-title":"Endemic nephropathy: the case for chronic poisoning by aristolochia","volume":"46","author":"Hranjec","year":"2005","journal-title":"Croat Med J"},{"issue":"29","key":"10.1016\/j.urolonc.2013.08.029_bib11","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.08.029_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Jelakovic","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ijc.26077","article-title":"TP53 Mutational signature for aristolochic acid: an environmental carcinogen","volume":"129","author":"Moriya","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.08.029_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.2011.428","article-title":"Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy","volume":"81","author":"De Broe","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijc.28013","article-title":"Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes","volume":"133","author":"Chen","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.08.029_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk","volume":"102","author":"Lai","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2013.08.029_bib17","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.08.029_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1755-8794-3-58","article-title":"Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder","volume":"3","author":"Zhang","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.urolonc.2013.08.029_bib19","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1158\/1078-0432.CCR-05-0411","article-title":"Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype","volume":"11","author":"Chapman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.08.029_bib20","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4161\/cbt.22280","article-title":"CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion","volume":"13","author":"Sasaki","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.urolonc.2013.08.029_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1997.4885","article-title":"A gene in human chromosome band Xq28 (GABRE) defines a putative new subunit class of the GABAA neurotransmitter receptor","volume":"45","author":"Wilke","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.urolonc.2013.08.029_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2010.02.011","article-title":"Statistical consideration for clinical biomarker research in bladder cancer","volume":"28","author":"Shariat","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: update 2013","volume":"63","author":"Roupret","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000330246","article-title":"Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors","volume":"87","author":"Jovanovic","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.urology.2007.06.1103","article-title":"Fluorescence in situ hybridization for detecting upper urinary tract tumors\u2014a preliminary report","volume":"70","author":"Akkad","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4149\/neo_2012_046","article-title":"Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology","volume":"59","author":"Huang","year":"2012","journal-title":"Neoplasma"},{"key":"10.1016\/j.urolonc.2013.08.029_bib29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.juro.2010.05.023","article-title":"Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance","volume":"184","author":"Johannes","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2008.10.015","article-title":"Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma","volume":"189","author":"Luo","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.urolonc.2013.08.029_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.eururo.2006.08.045","article-title":"Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma","volume":"51","author":"Marin-Aguilera","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2010.04.026","article-title":"Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours","volume":"58","author":"Mian","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.urology.2010.07.498","article-title":"Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients","volume":"77","author":"Xu","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0090-4295(01)01182-7","article-title":"Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report","volume":"58","author":"Lodde","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/ADJL7E810U1H42BJ","article-title":"Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings","volume":"127","author":"Yoder","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib36","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","author":"Yafi","year":"2013","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2013.08.029_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.urolonc.2010.08.006","article-title":"The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer","volume":"30","author":"Fernandez","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.eururo.2006.11.021","article-title":"Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival","volume":"51","author":"Lehmann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1464-410X.2007.06934.x","article-title":"The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically","volume":"100","author":"Saito","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1442-2042.2010.02671.x","article-title":"Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma","volume":"18","author":"Suyama","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00345-012-0946-6","article-title":"Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours","volume":"31","author":"Yates","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib42","first-page":"77","volume":"109","author":"Favaretto","year":"2012","journal-title":"Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma"},{"key":"10.1016\/j.urolonc.2013.08.029_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1148\/radiol.12111623","article-title":"Detection of urothelial tumors: comparison of urothelial phase with excretory phase CT urography\u2014a prospective study","volume":"264","author":"Metser","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.urolonc.2011.07.011","article-title":"Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma","volume":"31","author":"Messer","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib45","first-page":"52","volume":"163","author":"Guarnizo","year":"2000","journal-title":"Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach"},{"key":"10.1016\/j.urolonc.2013.08.029_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib47","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7863\/jum.2010.29.9.1277","article-title":"High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma imaging findings and pathologic correlation","volume":"29","author":"Matin","year":"2010","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.urolonc.2013.08.029_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.urology.2011.01.048","article-title":"Initial clinical experience with use of ureteral access sheaths in the diagnosis and treatment of upper tract urothelial carcinoma","volume":"78","author":"Gorin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.08.029_bib49","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdq333","article-title":"BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer","volume":"22","author":"Font","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2013.08.029_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/annonc\/mdl435","article-title":"Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy","volume":"18","author":"Bellmunt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib52","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1593\/neo.10402","article-title":"MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy","volume":"12","author":"Hoffmann","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.urolonc.2013.08.029_bib53","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1073\/pnas.0610292104","article-title":"A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery","volume":"104","author":"Lee","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.08.029_bib54","article-title":"Germline single-nucleotide polymorphisms (SNPs) associated with response of urothelial carcinoma (UC) to platinum-based therapy: the role of the host","volume":"29","author":"Gallagher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FPC.0b013e3283396c4e","article-title":"Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants","volume":"20","author":"O'Donnell","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.urolonc.2013.08.029_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ki.2010.440","article-title":"Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach","volume":"79","author":"Kwon","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2013.08.029_bib58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0192623309332992","article-title":"Discovery of metabolomics biomarkers for early detection of nephrotoxicity","volume":"37","author":"Boudonck","year":"2009","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.urolonc.2013.08.029_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Iyer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2013.08.029_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2217\/pgs.11.52","article-title":"Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group","volume":"12","author":"Patterson","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.urolonc.2013.08.029_bib61","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2013.08.029_bib62","doi-asserted-by":"crossref","unstructured":"Porten S, Siefker-Radtke A, Kamat AM, Dinney CPN, Matin SF. Survival outcomes in patients undergoing neoadjuvant chemotherapy for upper tract urothelial cell carcinoma. Presented at the genitourinary symposium, Orlando, Feb 15, 2013.","DOI":"10.1016\/j.juro.2013.02.462"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913003402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913003402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:00:26Z","timestamp":1761040826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913003402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1078143913003402"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.08.029","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highlights from the first symposium on upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}